Pharma outlook 2030: From evolution to revolution

20 Pages

The pharmaceutical industry is facing significant disruption, with increasing pressure on drug pricing and a shift from treatment to prevention and cures. By 2030, new technologies, personalized medicine, and patient empowerment will revolutionize healthcare. Companies must adapt to three emerging business models: the active portfolio company, the virtual value chain orchestrator, and the niche specialist. To thrive, pharma firms must embrace digital transformation, collaboration, and technological advancements, or risk losing ground to new entrants and tech giants.

Join for free to read

White Paper The AI Revolution: Transforming Marketing in Healthcare and…

Report McKinsey Technology Trends Outlook 2022

Report 2024 media and entertainment outlook

Report IoT Devices in Smart Commercial Buildings 2025 to 2030

More from KPMG

Report The Evolution of Loyalty Programs

Report Generative AI: From buzz to business value

White Paper From Promise to Practice

Report From telco to techco: Towards tomorrow’s telecom

Report

Pharma outlook 2030: From evolution to revolution

Pharma outlook 2030: From evolution to revolution

You Might Also Like

More from KPMG